Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 59651-026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 59651-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Amoxiclav Fig1)

Fig1 (Amoxiclav Fig1)
This is a prescription information for Aurobindo Pharma USA's Amoxicillin and Clavulanate Potassium Oral Suspension. Each 5 mL of reconstituted suspension contains 125 mg of amoxicillin USP and 31.25 mg of clavulanate potassium which is equivalent to 0.875 mg amoxicillin and 0.125 mg clavulanic acid. The directions suggest adding water to the dry powder until it flows freely, then adding the remaining water, shaking and storing the mixture at controlled room temperature before use. The prescription contains phenylalanine and should be discarded after 10 days. The printing zone contains a coded area for printing purposes.*
FDA Label Image

Package Label-principal Display Panel (250 mg/62.5 mg per 5 mL (75 mL Bottle Label))

Package Label-principal Display Panel (250 mg/62.5 mg per 5 mL (75 mL Bottle Label))
This is a medication called amoxicillin and clavulanate potassium oral suspension. Each 5 mL of the reconstituted suspension contains 250 mg of amoxicillin USP as the trihydrate and 62.5 mg of clavulanic acid as the clavulanate potassium. The medication should be stored in a cool and dry place at a controlled room temperature. The medication is distributed by Aurobindo Pharma USA, Inc. The medication is to be consumed by mixing with water and must be shaken well before use. The medication must be refrigerated after reconstitution and should be discarded after 10 days. The package contains phenylalanine per 5mL and should be discarded properly.*
FDA Label Image

Chemical Structure (Amoxiclav Str1)

FDA Label Image

Chemical Structure 1 (Amoxiclav Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.